Early Detection and Prevention of Alzheimer’s Disease: Role of Oxidative Markers and Natural Antioxidants
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Oxidative stress (OS) contributes to Alzheimer's disease (AD) pathology. OS can be a result of increased reactive oxygen/nitrogen species, reduced antioxidants, oxidatively damaged molecules, and/or a combination of these factors. Scientific literature is scarce for the markers of OS-specific for detecting AD at an early stage. The first aim of the current review is to provide an overview of the potential OS markers in the brain, cerebrospinal fluid (CSF), blood and/or urine that can be used for early diagnosis of human AD. The reason for exploring OS markers is that the proposed antioxidant therapies against AD appear to start too late to be effective. The second aim is to evaluate the evidence for natural antioxidants currently proposed to prevent or treat AD symptoms. To address these two aims, we critically evaluated the studies on humans in which various OS markers for detecting AD at an early stage were presented. Non-invasive OS markers that can detect mild cognitive impairment (MCI) and AD at an early stage in humans with greater specificity and sensitivity are primarily related to lipid peroxidation. However, a combination of OS markers, family history, and other biochemical tests are needed to detect the disease early on. We also report that the long-term use of vitamins (vitamin E as in almonds) and polyphenol-rich foods (curcumin/curcuminoids of turmeric, ginkgo biloba, epigallocatechin-3-gallate in green tea) seem justified for ameliorating AD symptoms. Future research on humans is warranted to justify the use of natural antioxidants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614 · cited 1×
“…1 July 2020 | Volume 12 | Article 231 damage in AD have been identified (Smith et al., 1997; NouroozZadeh et al., 1999; Lauderback et al., 2001; Halliwell, 2006; Dizdaroglu et al., 2015; Milne et al., 2015; Wang et al., 2015; Di Domenico et al., 2016, 2017; Dai et al., 2018; Ishii et al.,…”
BackgroundOxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954 · cited 3×
“For example, OS damage to the protein can be determined by measuring 3nitrotyrosine, protein carbonyls, methionine sulfoxide or highly reactive aldehydes; lipid damage by determining isoprostanes and lipid and cyclic peroxides; DNA damage by estimating 8hydroxy-deoxyguanosine (8OHdG); and RNA damage has been determine…”
BackgroundInfluentialWidespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Dysken, M. W., Sano, M., Asthana, S., Vertrees, J. E., Pallaki, M., Llorente, M., Love, S., Schellenberg, G. D., McCarten, J. R., Malphurs, J., et al. (2014) · JAMA · doi:10.1001/jama.2013.282834 · Cited by 628
Oxidative stress in the progression of Alzheimer disease in the frontal cortex
Ansari, M. A., & Scheff, S. W. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181cb5af4 · Cited by 605 · cited 1×
“, 2013) and in the frontal cortex (Ansari and Scheff, 2010) and hippocampus of MCI and AD (Scheff et al.”
BackgroundEvidence of increased oxidative damage in subjects with mild cognitive impairment
Keller, J. N., Schmitt, F. A., Scheff, S. W., Ding, Q., Chen, Q., Butterfield, D. A., & Markesbery, W. R. (2005) · Neurology · doi:10.1212/01.wnl.0000156156.13641.ba · Cited by 539
Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464 · cited 1×
“damage in AD have been identified (Smith et al., 1997; NouroozZadeh et al., 1999; Lauderback et al., 2001; Halliwell, 2006; Dizdaroglu et al., 2015; Milne et al., 2015; Wang et al., 2015; Di Domenico et al., 2016, 2017; Dai et al., 2018; Ishii et al., 2018), but only a limited data on the usefulness of these biomarker…”
BackgroundGreen tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project
Kuriyama, S., Hozawa, A., Ohmori, K., Shimazu, T., Matsui, T., Ebihara, S., Awata, S., Nagatomi, R., Arai, H., & Tsuji, I. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.355 · Cited by 428
Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377 · cited 2×
“Oxidative inactivation of several proteins in the hippocampus leads to the progression of AD from MCI (Butterfield et al., 2006a).”
BackgroundGalasko, D. R., Peskind, E., Clark, C. M., Quinn, J. F., Ringman, J. M., Jicha, G. A., Cotman, C., Cottrell, B., Montine, T. J., Thomas, R. G., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.85 · Cited by 377
The isoprostanes—25 years later
Milne, G. L., Dai, Q., & Roberts, L. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.10.007 · Cited by 335
Ahmed, T., & Gilani, A.-H. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.09.010 · Cited by 301
Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment
Wang, J., Markesbery, W. R., & Lovell, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03615.x · Cited by 260 · cited 1×
“Significantly elevated levels of 8OHG and 4,6-diamino-5formamidopyrimidine have been reported in the post-mortem MCI brains relative to the age-matched controls (Wang et al., 2006).”
BackgroundReed, T., Perluigi, M., Sultana, R., Pierce, W. M., Klein, J. B., Turner, D. M., Coccia, R., Markesbery, W. R., & Butterfield, D. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.12.007 · Cited by 257 · cited 1×
“Elevated levels of MDA and 4-HNE have been reported in the brains of subjects with MCI or early AD (Keller et al., 2005; Butterfield et al., 2006b; Greilberger et al., 2008; Reed et al., 2008; Lopez et al., 2013; Scheff et al., 2016).”
BackgroundDi Domenico, F., Tramutola, A., & Butterfield, D. A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.490 · Cited by 253
Butterfield, D. A., Reed, T., Perluigi, M., De Marco, C., Coccia, R., Cini, C., & Sultana, R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.017 · Cited by 246 · cited 2×
“Oxidative inactivation of several proteins in the hippocampus leads to the progression of AD from MCI (Butterfield et al., 2006a).”
BackgroundF4 ‐ Isoprostanes as Specific Marker of Docosahexaenoic Acid Peroxidation in Alzheimer's Disease
Nourooz‐Zadeh, J., Liu, E. H. C., Yhlen, B., Änggåard, E. E., & Halliwell, B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720734.x · Cited by 187
Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations
Schaffer, S., & Halliwell, B. (2012) · Genes & Nutrition · doi:10.1007/s12263-011-0255-5 · Cited by 178
Scheff, S. W., Ansari, M. A., & Mufson, E. J. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.030 · Cited by 100 · cited 2×
“Elevated levels of MDA and 4-HNE have been reported in the brains of subjects with MCI or early AD (Keller et al., 2005; Butterfield et al., 2006b; Greilberger et al., 2008; Reed et al., 2008; Lopez et al., 2013; Scheff et al., 2016).”
BackgroundDi Domenico, F., Pupo, G., Giraldo, E., Badìa, M.-C., Monllor, P., Lloret, A., Eugenia Schininà, M., Giorgi, A., Cini, C., Tramutola, A., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.004 · Cited by 97 · cited 3×
“Oxidative stress (OS) underlies MCI (Cervellati et al., 2014a; Di Domenico et al., 2016) and neurodegenerative diseases including AD (Dong et al., 2018).”
BackgroundGreen Tea Consumption Affects Cognitive Dysfunction in the Elderly: A Pilot Study
Ide, K., Yamada, H., Takuma, N., Park, M., Wakamiya, N., Nakase, J., Ukawa, Y., & Sagesaka, Y. (2014) · Nutrients · doi:10.3390/nu6104032 · Cited by 96
Polidori, M., & Nelles, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660706 · Cited by 69 · cited 2×
“The risk of AD appears to be decreased in elderly subjects with high plasma levels of vitamin E (tocopherols and tocotrienols; Mecocci and Polidori, 2012; Polidori and Nelles, 2014), but this could be due to a good overall diet rather than vitamin E alone.”
BackgroundSultana, R., Baglioni, M., Cecchetti, R., Cai, J., Klein, J. B., Bastiani, P., Ruggiero, C., Mecocci, P., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.001 · Cited by 64 · cited 3×
“Levels of 5-nitro-gamma-tocopherol, a marker of vitamin E damage, show a significant positive correlationwith protein carbonyls, protein-conjugatedHNE, and protein-bound 3-nitrotyrosine (Sultana et al., 2013) in MCI and AD (Table 1).”
BackgroundInfluentialMartínez de Toda, I., Miguélez, L., Vida, C., Carro, E., & De la Fuente, M. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190198 · Cited by 40
Cited by
Kodam, P., Sai Swaroop, R., Pradhan, S. S., Sivaramakrishnan, V., & Vadrevu, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-30892-6 · Cited by 82
Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease
Rani, S., Dhar, S. B., Khajuria, A., Gupta, D., Jaiswal, P. K., Singla, N., Kaur, M., Singh, G., & Barnwal, R. P. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01330-y · Cited by 48
Neuroprotective Roles of the Reverse Transsulfuration Pathway in Alzheimer’s Disease
Paul, B. D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.659402 · Cited by 42
“Regardless of the cause of AD, elevated oxidative stress has been observed in AD, which contributes to disease progression (Torres et al., 2011; Martínez de Toda et al., 2019; Arslan et al., 2020).”
Background
Metadata
- Authors
- Arslan, J., Jamshed, H., & Qureshi, H.
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2020-07-27
- Volume
- 12
- Pages
- 231-231
- ISSN
- 1663-4365 (ISSN-L)
- OpenAlex
- W3043832728
- Cited by
- 62
- References
- 24
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.